On the night of December 23, the Hungarian Gazette was published, full of new laws and regulations. One of them is a government decree amending the extra profit tax decree to impose a special tax on pharmaceutical manufacturers in proportion to their turnover. Another regulation increases the tax on insurance companies. The latest extra tax […]

The Hungarian pharmaceutical firm Gedeon Richter Plc. has announced an important change in the executive management of company on the website of the Budapest Stock Exchange. “The company hereby informs its honorable shareholders that with effect from November 15, 2022 Mr. Erik Bogsch resigns from his position regarding the direct supervision of Commercial, International and […]

Richter Gedeon Plc. has built and equipped a new molecular biology laboratory at its Debrecen site. The investment was part of a multi-year, partly EU-funded, HUF 4.83 billion research and development (R&D) project to support biotechnology drug development, the Budapest-listed pharmaceutical company told the state news agency MTI on Monday. According to the statement, the […]

Hungarian phrama company Gedeon Richter Plc. has announced that it has submitted a Type II Variation application for RYEQO® to the European Medicines Agency (EMA) for the treatment of moderate to severe pain associated with endometriosis in adult women of reproductive age with a history of previous medical or surgical treatment for their endometriosis. RYEQO® […]